View on Pubmed.gov 26599345 | View on doi.org 10.1080/1942086...
Glycan analysis of therapeutic glycoproteins.
- a Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring , Maryland.
Abstract
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems. The glycan moieties attached to the proteins can directly affect protein stability, bioactivity, and immunogenicity. Therefore, glycan variants of a glycoprotein product must be adequately analyzed and controlled to ensure product quality. However, the inherent complexity of protein glycosylation poses a daunting analytical challenge. This review provides an update of recent advances in glycan analysis, including the potential utility of lectin-based microarray for high throughput glycan profiling. Emphasis is placed on comparison of the major types of analytics for use in determining unique glycan features such as glycosylation site, glycan structure, and content.
References
Proteomics. 2008 Aug;8(15):3042-50
Curr Protoc Mol Biol. 2001 May;Chapter 17:Unit17.16
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Aug 1;997:162-78
Annu Rev Genomics Hum Genet. 2012;13:307-35
Cited by 180 citations (total)
Journal Article
A standardized method for lectin microarray-based tissue glycome mapping.
Electronic publication date November 9, 2018
Xia Zou [...] Atsushi Kuno et al.
The significance of glycomic profiling has been highlighted by recent findings that structural changes of glycans are observed in many...
Journal Article
Exploring the analytical power of the QTOF MS platform to assess monoclonal antibodies quality attributes.
Electronic publication date February 23, 2020
Ricardo A Gomes [...] PatrÃcia Gomes Alves et al.
The biopharmaceutical industry is growing at a fast pace, making nowadays 20% of the pharma market. Within this market, therapeutic...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •
- •
- •
Substances
- •
- •